Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2157-9024
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma ; volume:7 ; number:2 ; day:23 ; month:2 ; year:2018 ; pages:1-14 ; date:2.2018
Oncogenesis ; 7, Heft 2 (23.2.2018), 1-14, 2.2018
- Urheber
-
Di Martile, Marta
- Beteiligte Personen und Organisationen
-
Desideri, Marianna
Tupone, Maria Grazia
Buglioni, Simonetta
Antoniani, Barbara
Mastroiorio, Carlotta
Falcioni, Rita
Ferraresi, Virginia
Baldini, Nicola
Biagini, Roberto
Milella, Michele
Trisciuoglio, Daniela
Del Bufalo, Donatella
SpringerLink (Online service)
- DOI
-
10.1038/s41389-018-0026-x
- URN
-
urn:nbn:de:101:1-2018091022324003686919
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Di Martile, Marta
- Desideri, Marianna
- Tupone, Maria Grazia
- Buglioni, Simonetta
- Antoniani, Barbara
- Mastroiorio, Carlotta
- Falcioni, Rita
- Ferraresi, Virginia
- Baldini, Nicola
- Biagini, Roberto
- Milella, Michele
- Trisciuoglio, Daniela
- Del Bufalo, Donatella
- SpringerLink (Online service)
Ähnliche Objekte (12)
Histone deacetylase 6 in cancer
Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone deacetylase 6 in cancer
Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone deacetylase 6 in cancer
Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro